- Home
- OCGN vs TEAF Comparison
OCGN vs TEAF Comparison
Compare OCGN & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- TEAF
- Stock Information
- Founded
- OCGN 2013
- TEAF 2017
- Country
- OCGN United States
- TEAF United States
- Employees
- OCGN N/A
- TEAF N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- OCGN Health Care
- TEAF Finance
- Exchange
- OCGN Nasdaq
- TEAF Nasdaq
- Market Cap
- OCGN 189.6M
- TEAF 152.6M
- IPO Year
- OCGN N/A
- TEAF N/A
- Fundamental
- Price
- OCGN $0.67
- TEAF $11.36
- Analyst Decision
- OCGN Strong Buy
- TEAF
- Analyst Count
- OCGN 3
- TEAF 0
- Target Price
- OCGN $6.33
- TEAF N/A
- AVG Volume (30 Days)
- OCGN 3.2M
- TEAF 56.1K
- Earning Date
- OCGN 05-09-2025
- TEAF 01-01-0001
- Dividend Yield
- OCGN N/A
- TEAF 9.20%
- EPS Growth
- OCGN N/A
- TEAF N/A
- EPS
- OCGN N/A
- TEAF N/A
- Revenue
- OCGN $4,522,000.00
- TEAF N/A
- Revenue This Year
- OCGN N/A
- TEAF N/A
- Revenue Next Year
- OCGN N/A
- TEAF N/A
- P/E Ratio
- OCGN N/A
- TEAF N/A
- Revenue Growth
- OCGN N/A
- TEAF N/A
- 52 Week Low
- OCGN $0.52
- TEAF $11.11
- 52 Week High
- OCGN $2.06
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- OCGN 46.49
- TEAF 54.15
- Support Level
- OCGN $0.65
- TEAF $11.31
- Resistance Level
- OCGN $0.75
- TEAF $11.47
- Average True Range (ATR)
- OCGN 0.05
- TEAF 0.16
- MACD
- OCGN -0.01
- TEAF 0.04
- Stochastic Oscillator
- OCGN 15.38
- TEAF 71.15
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.